NRx Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
16 Dec 22 | BuyUS$33,000 | Seth Van Voorhees | Individual | 30,000 | US$1.10 | |
16 Dec 22 | BuyUS$58,500 | Stephen Willard | Individual | 50,000 | US$1.17 | |
07 Dec 22 | SellUS$400,000 | Jonathan Javitt | Individual | 400,000 | US$1.00 | |
28 Nov 22 | BuyUS$14,663 | Patrick Flynn | Individual | 11,750 | US$1.25 | |
25 Nov 22 | BuyUS$18,215 | Seth Van Voorhees | Individual | 16,337 | US$1.12 | |
18 Nov 22 | BuyUS$514,905 | Chaim Hurvitz | Individual | 500,000 | US$1.10 | |
29 Jul 22 | SellUS$791,433 | Glytech, LLC | Company | 784,063 | US$1.01 | |
07 Jun 22 | SellUS$303,910 | Glytech, LLC | Company | 445,712 | US$0.70 | |
01 Jun 22 | BuyUS$58,000 | Jonathan Javitt | Individual | 100,000 | US$0.58 |
Insider Trading Volume
Insider Buying: NRXP insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 8,408,967 | 12.4% |
Private Companies | 9,694,568 | 14.3% |
Individual Insiders | 18,419,471 | 27.2% |
General Public | 31,118,308 | 46.0% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
14,168,329 | $16.6m | -4.71% | no data | |||
9,643,234 | $11.3m | -2.33% | no data | |||
3,329,812 | $3.9m | 0% | 8.68% | |||
2,144,793 | $2.5m | 30.4% | no data | |||
1,440,265 | $1.7m | 31.57% | no data | |||
1,050,000 | $1.2m | 5% | no data | |||
876,181 | $1.0m | 0% | no data | |||
648,538 | $758.8k | -0.58% | no data | |||
593,933 | $694.9k | 0% | 6.06% | |||
590,336 | $690.7k | 36.42% | no data | |||
320,627 | $375.1k | 3.95% | no data | |||
300,000 | $351.0k | 0% | 100% | |||
153,700 | $179.8k | 0% | no data | |||
114,240 | $133.7k | 0% | no data | |||
113,584 | $132.9k | -34.32% | no data | |||
83,300 | $97.5k | 0% | no data | |||
66,640 | $78.0k | 0% | no data | |||
66,640 | $78.0k | 0% | no data | |||
63,290 | $74.0k | 0% | 0.01% | |||
59,313 | $69.4k | 5.23% | no data | |||
58,598 | $68.6k | 0% | no data | |||
50,000 | $58.5k | 0% | no data | |||
46,337 | $54.2k | 0% | no data | |||
43,501 | $50.9k | 0% | 0.01% | |||
43,093 | $50.4k | 0% | no data |